148 related articles for article (PubMed ID: 11392526)
1. 31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease.
Felderhoff-Mueser U; Sperner J; Konstanzcak P; Navon R; Weschke B
J Child Neurol; 2001 May; 16(5):377-80. PubMed ID: 11392526
[TBL] [Abstract][Full Text] [Related]
2. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect.
Navon R; Kolodny EH; Mitsumoto H; Thomas GH; Proia RL
Am J Hum Genet; 1990 Apr; 46(4):817-21. PubMed ID: 2278539
[TBL] [Abstract][Full Text] [Related]
3. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
4. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
5. Tay-Sachs disease: a case report.
Arisoy AE; Ozden S; Ciliv G; Ozalp I
Turk J Pediatr; 1995; 37(1):51-6. PubMed ID: 7732608
[TBL] [Abstract][Full Text] [Related]
6. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
Navon R; Proia RL
Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
[TBL] [Abstract][Full Text] [Related]
7. Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients.
Neudorfer O; Pastores GM; Zeng BJ; Gianutsos J; Zaroff CM; Kolodny EH
Genet Med; 2005 Feb; 7(2):119-23. PubMed ID: 15714079
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Tay-Sachs disease.
Barritt AW; Anderson SJ; Leigh PN; Ridha BH
Pract Neurol; 2017 Oct; 17(5):396-399. PubMed ID: 28739864
[TBL] [Abstract][Full Text] [Related]
9. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases.
Willner JP; Grabowski GA; Gordon RE; Bender AN; Desnick RJ
Neurology; 1981 Jul; 31(7):787-98. PubMed ID: 6454083
[TBL] [Abstract][Full Text] [Related]
10. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
Christopher R; Rangaswamy GR; Shetty KT
Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
[TBL] [Abstract][Full Text] [Related]
11. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
[TBL] [Abstract][Full Text] [Related]
12. [Tay-Sachs disease in non-Jewish infant in Israel].
Nadim N
Harefuah; 2012 Jan; 151(1):16-7, 63. PubMed ID: 22670494
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy in three children with Tay-Sachs disease.
Aydin K; Bakir B; Tatli B; Terzibasioglu E; Ozmen M
Pediatr Radiol; 2005 Nov; 35(11):1081-5. PubMed ID: 16079982
[TBL] [Abstract][Full Text] [Related]
15. Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues.
Rosebush PI; MacQueen GM; Clarke JT; Callahan JW; Strasberg PM; Mazurek MF
J Clin Psychiatry; 1995 Aug; 56(8):347-53. PubMed ID: 7635850
[TBL] [Abstract][Full Text] [Related]
16. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings.
Hund E; Grau A; Fogel W; Forsting M; Cantz M; Kustermann-Kuhn B; Harzer K; Navon R; Goebel HH; Meinck HM
J Neurol Sci; 1997 Jan; 145(1):25-31. PubMed ID: 9073025
[TBL] [Abstract][Full Text] [Related]
17. Late-onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr180-->His) in the Hex A alpha-chain gene.
De Gasperi R; Gama Sosa MA; Battistini S; Yeretsian J; Raghavan S; Zelnik N; Leshinsky E; Kolodny EH
Neurology; 1996 Aug; 47(2):547-52. PubMed ID: 8757036
[TBL] [Abstract][Full Text] [Related]
18. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA
Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652
[TBL] [Abstract][Full Text] [Related]
19. [Hexosaminidase deficiency as differential spinocerebellar diseases].
Förster A; Heuss D; Claus D
Nervenarzt; 1999 Feb; 70(2):162-6. PubMed ID: 10098152
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging in Tay-Sachs disease].
Ozawa H; Sugai K; Sasaki S
No To Shinkei; 1995 Aug; 47(8):800-1. PubMed ID: 7546928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
